Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
The sex-specific contribution of G-protein-coupled receptors to impaired neurovascular coupling in Alzheimer's disease
EF 2024-25
Résumé
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline; currently, no effective treatment exists. AD pathology involves accumulation of B-amyloid (AB42) oligomers in the brain, which complexes with metabotropic glutamate receptor 5 (mGluR5) and disrupts its signalling. To maintain brain structure and function, mGluR5 in astrocytes regulate cerebral blood flow (CBF) through neurovascular coupling (NVC). Impaired CBF and NVC are prevalent features in AD; thus, AB42 may disrupt astroglial mGluR5 signalling and cause cognitive decline by impairing CBF and NVC.
Women are twice more likely than men to be afflicted by AD, suggesting that AD pathophysiological mechanisms act in a sex-based manner. Previously, it was found that AB42 reduced mGluR5-regulated autophagy in male but not female mouse primary neuronal cultures. However, the interplay of sex hormones and mGluR5 signalling in astrocytes and their role in AB pathologies has not been addressed.
In this study, it is hypothesized that sex hormones alter astroglial mGluR5 signalling, leading to sex-specific impacts on NVC in AD. Our hypothesis will be tested through two integrated aims:
1) Assess how sex hormones alter mGluR5-mediated regulation of CBF, cognitive function, and AB42 pathology.
2) Study the effects of sex hormones on mGluR5-mediated modifications to the structure of the neurovascular unit.
Understanding sex-based differences in the role of mGluR5 in AD would help revolutionize how we consider mGluR5 as a drug target for certain patient populations (ex. menopausal women), and have significant implications for future novel treatment strategies and clinical trial design.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529790
Name
Ye Emily
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The sex-specific contribution of G-protein-coupled receptors to impaired neurovascular coupling in Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Astrocytes; Cerebral Blood Flow; Cognitive Function; Metabotropic Glutamate Receptor 5; Neurovascular Coupling; Sex Hormones
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline; currently, no effective treatment exists. AD pathology involves accumulation of B-amyloid (AB42) oligomers in the brain, which complexes with metabotropic glutamate receptor 5 (mGluR5) and disrupts its signalling. To maintain brain structure and function, mGluR5 in astrocytes regulate cerebral blood flow (CBF) through neurovascular coupling (NVC). Impaired CBF and NVC are prevalent features in AD; thus, AB42 may disrupt astroglial mGluR5 signalling and cause cognitive decline by impairing CBF and NVC.
Women are twice more likely than men to be afflicted by AD, suggesting that AD pathophysiological mechanisms act in a sex-based manner. Previously, it was found that AB42 reduced mGluR5-regulated autophagy in male but not female mouse primary neuronal cultures. However, the interplay of sex hormones and mGluR5 signalling in astrocytes and their role in AB pathologies has not been addressed.
In this study, it is hypothesized that sex hormones alter astroglial mGluR5 signalling, leading to sex-specific impacts on NVC in AD. Our hypothesis will be tested through two integrated aims:
1) Assess how sex hormones alter mGluR5-mediated regulation of CBF, cognitive function, and AB42 pathology.
2) Study the effects of sex hormones on mGluR5-mediated modifications to the structure of the neurovascular unit.
Understanding sex-based differences in the role of mGluR5 in AD would help revolutionize how we consider mGluR5 as a drug target for certain patient populations (ex. menopausal women), and have significant implications for future novel treatment strategies and clinical trial design.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ye, Emily
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~